This article is more than 5 years old. Information may no longer be current.
Drug development expert joins Yale
Click Here to Manage Email Alerts
Patricia M. LoRusso, DO, a leading expert on the development of new cancer drugs through clinical trials, has been appointed professor of medicine and associate director of innovative medicine at Yale Cancer Center.
LoRusso previously held several leadership positions at Wayne State University’s Barbara Karmanos Cancer Institute. She most recently served as director of the phase 1 clinical trials program and director of the Eisenberg Center for Experimental Therapeutics.
Patricia M. LoRusso
“Pat LoRusso is a pre-eminent leader in early phase drug development, and she joins the cancer center at a time during which we have committed to accelerating the process of getting new drugs to patients,” Thomas J. Lynch, MD, director of Yale Cancer Center and physician-in-chief at Smilow Cancer Hospital at Yale New Haven, said in a press release. “She will help the center continue to make significant contributions to the global cancer problem.”
LoRusso has served as co-chair of the NCI’s Cancer Therapy Evaluation Program Investigational Drug Steering Committee. She also served on the scientific committee of the American Association for Cancer Research, as well as ASCO’s education and scientific committees.
“My primary mission is to make a difference in human lives, and one of the ways to do this is by bringing the very latest therapies to patients through clinical trials,” LoRusso said in a press release. “Yale Cancer Center has great research, great leadership, and a passionate group of scientists and physicians dedicated to fighting cancer, and this is where I want to apply my skills and passion.”